Equities

Themis Medicare Ltd

THEMISMED:NSI

Themis Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)276.60
  • Today's Change-3.00 / -1.07%
  • Shares traded78.53k
  • 1 Year change+64.64%
  • Beta1.2141
Data delayed at least 15 minutes, as of Nov 08 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments99125203
Total Receivables, Net1,9111,6541,217
Total Inventory706690608
Prepaid expenses625541
Other current assets, total15412173
Total current assets2,9322,6452,142
Property, plant & equipment, net1,7041,6401,456
Goodwill, net------
Intangibles, net5.527.709.89
Long term investments898704581
Note receivable - long term12512869
Other long term assets--1420
Total assets5,6645,1404,278
LIABILITIES
Accounts payable473400319
Accrued expenses------
Notes payable/short-term debt474489431
Current portion long-term debt/capital leases217150123
Other current liabilities, total383352222
Total current liabilities1,5461,3911,095
Total long term debt268284243
Total debt958924797
Deferred income tax746965
Minority interest(0.01)(0.01)(0.01)
Other liabilities, total000
Total liabilities1,8871,7451,403
SHAREHOLDERS EQUITY
Common stock929292
Additional paid-in capital------
Retained earnings (accumulated deficit)3,6853,3032,783
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.47)(0.54)(0.43)
Total equity3,7773,3942,875
Total liabilities & shareholders' equity5,6645,1404,278
Total common shares outstanding929292
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.